Clinical Trials Directory

Trials / Completed

CompletedNCT03197051

Impact of Perioperative Shedding of the Endothelial Glycocalyx on the Incidence of Postoperative Acute Kidney Injury in Patients Undergoing Valvular Heart Surgery.

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Endothelial glycocalyx, the luminal structure of healthy vasculature, plays critical roles in regulation of inflammatory responses, vascular permeability, blood coagulation. It can be easily damaged by ischemia/reperfusion, hypoxemia, oxidative stress, endotoxin. Accordingly, the relationship between the shedding of endothelial glycocalyx and the prognosis of diseases such as diabetes mellitus, atherosclerosis, malignancy has been researched. In cases of cardiac surgery, patients cannot help but be exposed to ischemia/reperfusion, oxidative stress which can damage endothelial glycocalyx. In this research, the investigators would like to discover the impact of perioperative shedding of the endothelial glycocalyx on the incidence of postoperative acute kidney injury in patients undergoing valvular heart surgery.

Detailed description

Syndecan-1, Heparan sulfate serve as biomarkers of glycocalyx degradation. Both biomarkers will be measured 2 times, before the anesthetic induction, and immediately after weaning from cardiopulmonary bypass, during the valvular heart surgery. Postoperative acute kidney injury up to postoperative 48 hours, Composite morbidity and mortality up to postoperative 30 days will be checked.

Conditions

Timeline

Start date
2017-06-25
Primary completion
2018-07-11
Completion
2018-07-11
First posted
2017-06-23
Last updated
2019-01-11

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03197051. Inclusion in this directory is not an endorsement.